Submitted:
21 October 2023
Posted:
23 October 2023
You are already at the latest version
Abstract
Keywords:
Introduction
1. In-depth analyses dispute the 3 supporting evidences of Theory of H. pylori
2. Alternative interpretations for two observations explainable by H. pylori
3. Applying historical definition of ‘etiological factor’ or ‘causality’ to H. pylori
4. Existing data presented a controversial view on the role of H. pylori
5. Epidemiological studies dispute the causal role of H. pylori in peptic ulcers
6. Characteristics of peptic ulcers dispute the causal role of H. pylori in this disease
7. Historical observations/phenomenon dispute the role of H. pylori in peptic ulcers
8. The comparative effectiveness research identified an illusion in medicine
Conclusions
Supplementary Materials
Author Contributions
Funding Statement
Data Availability Statement
Acknowledgements
Conflict of Interest
Ethics Statement
References
- Fatović-Ferenčić S, Banić M. No acid, no ulcer: Dragutin (Carl) Schwarz (1868-1917), the man ahead of his time. Dig Dis 2011, 29, 507–10. [Google Scholar] [CrossRef] [PubMed]
- von Bergmann, G. Ulcus duodeni und vegetatives nerve system. Berl Klin Wchnscher 1913, 50, 2374. [Google Scholar]
- Wolowitz, HM. Oral involvement in peptic ulcer. J Consult Psychol 1967, 31, 418–9. [Google Scholar] [CrossRef]
- Selye H. The physiology and pathology of exposure to stress. Oxford, England: : Acta 1950.
- Dong SXM, Chang CCY, Rowe KJ. A collection of the etiological theories, characteristics, and observations/phenomena of peptic ulcers in existing data. Data Br 2018, 19, 1058–67. [Google Scholar] [CrossRef]
- Kuang H. Peptic Ulcer Diseases. Beijing: : People’s Medical Publishing House 1990.
- Susser M, Stein Z. Civilization and Peptic Ulcer. Lancet 1962, 279, 116–119. [Google Scholar] [CrossRef]
- Sonnenberg A, Wasserman IH, Jacobsen SJ. Monthly variation of hospital admission and mortality of peptic ulcer disease: A reappraisal of ulcer periodicity. Gastroenterology 1992, 103, 1192–8. [Google Scholar] [CrossRef]
- Susser, M. Peptic Ulcer: Rise and Fall. Christie DA, Tansey EM (eds). Wellcome Witnesses to Twentieth Century Medicine. Vol.14, 2002. London: The Wellcome Trust Centre for the History of Medicine, 2002, £10.00 ISBN: 0-85484-084-2. Int J Epidemiol 2003, 32, 674–5. [Google Scholar] [CrossRef]
- Damon A, Polednak AP. Constitution, genetics, and body form in peptic ulcer: A review. J Chronic Dis 1967, 20, 787–802. [Google Scholar] [CrossRef]
- Ciacci C, Mazzacca G. The history of Helicobacter pylori: A reflection on the relationship between the medical community and industry. Dig Liver Dis 2006, 38, 778–80. [Google Scholar] [CrossRef]
- Marshall, BJ. Peptic Ulcer: An Infectious Disease? Hosp Pract 1987, 22, 87–96. [Google Scholar] [CrossRef] [PubMed]
- Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet (London, England) 1988, 2, 1437–42. [Google Scholar] [CrossRef]
- Hobsley M, Tovey FI, Bardhan KD, et al. Does Helicobacter pylori really cause duodenal ulcers? No. BMJ 2009, 339, b2788. [Google Scholar] [CrossRef]
- Peterson, WL. Review article: Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991, 324, 1043–8. [Google Scholar] [CrossRef]
- Veldhuyzen van Zanten SJ, Sherman PM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ 1994, 150, 177–85. [Google Scholar]
- Walsh JH, Peterson WL. The Treatment of Helicobacter pylori Infection in the Management of Peptic Ulcer Disease. N Engl J Med 1995, 333, 984–91. [Google Scholar] [CrossRef] [PubMed]
- Graham, DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991, 6, 105–13. [Google Scholar] [CrossRef] [PubMed]
- Li H, KALIES I, MELLGÅRD B, et al. A Rat Model of Chronic Helicobacter pylori Infection: Studies of Epithelial Cell Turnover and Gastric Ulcer Healing. Scand J Gastroenterol 1998, 33, 370–8. [Google Scholar] [CrossRef] [PubMed]
- Konturek SJ, Bielanski W, Plonka M, et al. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers. Scand J Gastroenterol 2003, 38, 923–30. [Google Scholar] [CrossRef] [PubMed]
- Rauws EJ, Tytgat GNJ. Helicobacter pylori in duodenal and gastric ulcer disease. Baillière’s Clin Gastroenterol 1995, 9, 529–47. [Google Scholar] [CrossRef] [PubMed]
- Ford, Alexander C. ; Tally NJ. Head to Head: Does Helicobacter pylori really cause duodenal ulcers? Yes. BMJ 2009, 339, b2784. [Google Scholar] [CrossRef] [PubMed]
- Record CO, Rubin PC. Controversies in Management: Helicobacter pylori is not the causative agent. BMJ 1994, 309, 1571–2. [Google Scholar] [CrossRef]
- Kate V, Ananthakrishnan N, Tovey FI. Is Helicobacter pylori Infection the Primary Cause of Duodenal Ulceration or a Secondary Factor? A Review of the Evidence. Gastroenterol Res Pract 2013, 2013, 1–8. [Google Scholar] [CrossRef]
- Tovey FI, Hobsley M. Review: is Helicobacter pylori the primary cause of duodenal ulceration? J Gastroenterol Hepatol 1999, 14, 1053–6. [Google Scholar] [CrossRef]
- Tan VPY, Wong BCY. Helicobacter pylori and gastritis: Untangling a complex relationship 27 years on. J Gastroenterol Hepatol 2011, 26, 42–5. [Google Scholar] [CrossRef]
- Musumba C, Pritchard DM, Pirmohamed M. Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. Aliment Pharmacol Ther 2009, 30, 517–31. [Google Scholar] [CrossRef]
- Gisbert JP, Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther 2009, 30, 791–815. [Google Scholar] [CrossRef]
- Carton J, Daly R, Ramani P. Clinical Pathology. Oxford University Press 2007.
- Holcombe, C. Helicobacter pylori: the African enigma. Gut 1992, 33, 429–31. [Google Scholar] [CrossRef]
- Dong SXM, Chang CCY. Philosophical Principles of Life Science. Taipei: : Wunan Culture Enterprise 2012.
- Dong SXM. The Hyperplasia and Hypertrophy of Gastrin and Parietal Cells Induced by Chronic Stress Explain the Pathogenesis of Duodenal Ulcers. J Ment Heal Clin Psychol 2022, 6, 1–12. [Google Scholar] [CrossRef]
- Xin Min Dong, S. A Novel Psychopathological Model Explains the Pathogenesis of Gastric Ulcers. J Ment Heal Clin Psychol 2022, 6, 13–24. [Google Scholar] [CrossRef]
- Dong SXM. Painting a complete picture of the pathogenesis of peptic ulcers. Jounral Ment Heal Clin Psychol 2022, 6, 32–43. [Google Scholar] [CrossRef]
- Dong SXM. Novel data analysese explain the birth-cohort phenomenon of peptic ulcers. Preprint Published Online First: 2023. [CrossRef]
- Dong SXM. Novel data analyses explain the seasonal variations of peptic ulcers. Preprint 2023, :2023020271. [CrossRef]
- Taskin V, Gurer I, Ozyilkan E, et al. Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction. Helicobacter 2000, 5, 38–40. [Google Scholar] [CrossRef]
- Freston, JW. Role of proton pump inhibitors in non-H. pylori-related ulcers. Aliment Pharmacol Ther 2001, 15, 2–5. [Google Scholar] [CrossRef]
- Penston, JG. Helicobacter pylori eradication–understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994, 8, 369–89. [Google Scholar] [CrossRef]
- Borody TJ, Cole P, Noonan S, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989, 151, 431–5. [Google Scholar] [CrossRef]
- Cutler A V, Schubert TT. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993, 88, 1359–61. [Google Scholar]
- Okimoto T, Murakami K, Sato R, et al. Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan. Helicobacter 2003, 8, 186–91. [Google Scholar] [CrossRef]
- Katz, P. Once an ulcer, always an ulcer? Am J Gastroenterol 1994, 89, 808–9. [Google Scholar]
- Miller JP, Faragher EB. Relapse of duodenal ulcer: does it matter which drug is used in initial treatment? BMJ 1986, 293, 1117–8. [Google Scholar] [CrossRef]
- Bateson, EM. Duodenal Ulcer-Does it Exist in Australian Aborigines? Aust N Z J Med 1976, 6, 545–7. [Google Scholar] [CrossRef]
- Hesse, FG. Incidence of cholecystitis and other diseases among Pima Indians of Southern Arizona. J Am Med Assoc 1959, 170, 1789–90. [Google Scholar] [CrossRef]
- Sievers ML, Marquis JR. Duodenal Ulcer among Southwestern American Indians. Gastroenterology 1962, 42, 566–9. [Google Scholar] [CrossRef]
- Hill, AB. The Environment and Disease: Association or Causation? Proc R Soc Med 1965, 58, 295–300. [Google Scholar] [CrossRef]
- van Reekum R, Streiner DL, Conn DK. Applying Bradford Hill’s Criteria for Causation to Neuropsychiatry. J Neuropsychiatry Clin Neurosci 2001, 13, 318–25. [Google Scholar] [CrossRef]
- Fedak KM, Bernal A, Capshaw ZA, et al. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol 2015, 12, 14. [Google Scholar] [CrossRef]
- Wulff, HR. Rational Diagnosis and Treatment. J Med Philos 1986, 11, 123–34. [Google Scholar] [CrossRef]
- Ross, LN. The doctrine of specific etiology. Biol Philos 2018, 33, 37. [Google Scholar] [CrossRef]
- Susser, M. What is a Cause and How Do We Know One? A Grammar for Pragmatic Epidemiology. Am J Epidemiol 1991, 133, 635–48. [Google Scholar] [CrossRef]
- Jones, MP. The role of psychosocial factors in peptic ulcer disease: Beyond Helicobacter pylori and NSAIDs. J Psychosom Res 2006, 60, 407–12. [Google Scholar] [CrossRef]
- Kato S, Nishino Y, Ozawa K, et al. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. J Gastroenterol 2004, 39, 734–8. [Google Scholar] [CrossRef]
- Iijima K, Kanno T, Koike T, et al. Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: Negative idiopathic ulcers in Asia. World J Gastroenterol 2014, 20, 706. [Google Scholar] [CrossRef]
- Witthöft M. Etiology/Pathogenesis. In: Gellman MD, Turner JR, eds. Encyclopedia of Behavioral Medicine. Springer, New York, NY 2013. [CrossRef]
- Wikipedia. Barry Marshall. Wikipedia, Free Encycl. 2020.https://en.wikipedia.org/wiki/Barry_Marshall.
- Porro GB, Lazzaroni M. Campylobacter pylori and ulcer recurrence. Lancet 1988, 331, 593. [Google Scholar] [CrossRef]
- Rauws EAJJ, Tytgat GNJJ. Helicobacter pylori in duodenal and gastric ulcer disease. Baillieres Clin Gastroenterol 1995, 9, 529–47. [Google Scholar] [CrossRef]
- Alam K, Schubert TT, Bologna SD, et al. Increased Density of Helicobacter pylori on Antral Biopsy is Associated with Severity of Acute and Chronic Inflammation and Likelihood of Duodenal Ulceration. Am J Gastroenterol 1992, 87, 424–8. [Google Scholar]
- Elitsur Y, Lawrence Z. Non-Helicobacter pylori related duodenal ulcer disease in children. Helicobacter 2001, 6, 239–43. [Google Scholar] [CrossRef]
- Linda R, Ransohoff DF. Is helicobacter pylori a cause of duodenal ulcer? A methodologic critique of current evidence. Am J Med 1991, 91, 566–72. [Google Scholar] [CrossRef]
- Zelickson MS, Bronder CM, Johnson BL, et al. Helicobacter pylori is not the predominant etiology for peptic ulcers requiring operation. Am Surg 2011, 77, 1054–60. [Google Scholar] [CrossRef]
- Scholl, R. Peptic ulcer disease and helicobacter pylori: How we know what we know [Article in German]. Ther Umschau 2015, 72, 475–80. [Google Scholar] [CrossRef] [PubMed]
- Taylor, F. Essential Epidemiology: Principles and Applications. Int J Epidemiol 2003, 32, 671–671. [Google Scholar] [CrossRef]
- Blumenthal U, Fleisher J, Esrey S, et al. Epidemiology – a tool for the assessment of risk. In: Bartram LF and J, ed. Water Quality: Guidelines, Standards and Health. London, UK.: : IWA Publishing 2001. 135–60.http://discovery.ucl.ac.uk/76470/.
- Jin J, Zhou S, Xu Q, et al. Identification of risk factors in epidemiologic study based on ROC curve and network. Sci Rep 2017, 7, 46655. [Google Scholar] [CrossRef]
- Susser M, Stein Z. Civilization and peptic ulcer*. Int J Epidemiol 2002, 31, 13–7. [Google Scholar] [CrossRef] [PubMed]
- Marshall, B. Commentary: Helicobacter as the ‘environmental factor’ in Susser and Stein’s cohort theory of peptic ulcer disease. Int J Epidemiol 2002, 31, 21–2. [Google Scholar] [CrossRef] [PubMed]
- Sonnenberg, A. Causes underlying the birth-cohort phenomenon of peptic ulcer: analysis of mortality data 1911–2000, England and Wales. Int J Epidemiol 2006, 35, 1090–7. [Google Scholar] [CrossRef] [PubMed]
- Graham DY, Yamaoka Y. H. pylori and cagA: Relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter 1998, 3, 145–51. [Google Scholar] [CrossRef] [PubMed]
- Henriksson AE, Edman AC, Nilsson I, et al. Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer. ScandJ Gastroenterol 1998, 33, 1030–3. [Google Scholar] [CrossRef] [PubMed]
- Hurlimann S, Dür S, Schwab P, et al. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease. Am J Gastroenterol 1998, 93, 1277–85. [Google Scholar] [CrossRef] [PubMed]
- Yamaoka Y, Kodama T, Kita M, et al. Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut 1999, 45, 804–11. [Google Scholar] [CrossRef] [PubMed]
- Weel JFL, van der Hulst RWM, Gerrits Y, et al. The Interrelationship between Cytotoxin-Associated Gene A, Vacuolating Cytotoxin, and Helicobacter pylori-Related Diseases. J Infect Dis 1996, 173, 1171–5. [Google Scholar] [CrossRef]
- Savarino V, Mela GS, Zentilin P, et al. Are Duodenal Ulcer Seasonal Fluctuations Paralleled by Seasonal Changes in 24-Hour Gastric Acidity and Helicobacter Pylori Infection? J Clin Gastroenterol 1996, 22, 178–81. [Google Scholar] [CrossRef]
- Raschka C, Schorr W, Koch HJ. Is There Seasonal Periodicity in the Prevalence of Helicobacter Pylori? Chronobiol Int 1999, 16, 811–9. [Google Scholar] [CrossRef]
- Oderda G, Vaira D, Holton J, et al. Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci 1991, 36, 572–6. [Google Scholar] [CrossRef] [PubMed]
- Watkinson, G. The Incidence of Chronic Peptic Ulcer Found at Necropsy: A Study of 20,000 Examinations Performed in Leeds in 1930-49 and in England and Scotland in 1956. Gut 1960, 1, 14–30. [Google Scholar] [CrossRef] [PubMed]
- Levij IS, Fuente AADELA. A post-mortem study of gastric and duodenal peptic lesions: Part II Correlations with other pathological conditions. Gut 1963, 4, 354–9. [Google Scholar] [CrossRef] [PubMed]
- Lindström, CG. Gastric and Duodenal Peptic Ulcer Disease in a Well-Defined Population: A Prospective Necropsy Study in Malmö, Sweden. Scand J Gastroenterol 1978, 13, 139–43. [Google Scholar] [CrossRef] [PubMed]
- van der Merwe CF, te Winkel W. Ten-year observation of peptic ulceration at Ga-Rankuwa Hospital, Pretoria--1979-1988. S Afr Med J 1990, 78, 196–9. [Google Scholar]
- Moshal MG, Spitaels JM, Robbs J V, et al. Eight-year experience with 3392 endoscopically proven duodenal ulcers in Durban, 1972–1979. Rise and fall of duodenal ulcers and a theory of changing dietary and social factors. Gut 1981, 22, 327–31. [Google Scholar] [CrossRef]
- Shi H, Xiong H, Qian W, et al. Helicobacter pylori infection progresses proximally associated with pyloric metaplasia in age-dependent tendency: a cross-sectional study. BMC Gastroenterol 2018, 18, 158. [Google Scholar] [CrossRef]
- Smout AJPM, Akkarmans LMA. Motility of the gastroinal tract. Beijing, page 18-22, : Science Press 1996.
- Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol 2002, 97, 2950–61. [Google Scholar] [CrossRef]
- Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998, 93, 1409–15. [Google Scholar] [CrossRef]
- Vaira D, Menegatti M, Miglioli M. What Is the Role of Helicobacter pylori in Complicated Ulcer Disease? Gastroenterology 1997, 113, S78–S84. [Google Scholar] [CrossRef]
- Gisbert JP, Pajares JM. Review: Helicobacter pylori and bleeding peptic ulcer: what is the prevalence of the infection in patients with this complication? Scand J Gastroenterol 2003, 38, 2–9. [Google Scholar] [CrossRef]
- Gisbert, J. Helicobacter pylori and perforated peptic ulcer. Prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis 2004, 36, 116–20. [Google Scholar] [CrossRef]
- Szabo, S. Duodenal ulcer disease animal model: cysteamine-induced acute and chronic duodenal ulcer in the Rat. Am J Pathol 1978, 93, 273–6. [Google Scholar]
- Editors Biography.com. Barry J. Marshall Biography.com. 2014.https://www.biography.com/people/barry-j-marshall-40435 (accessed 10 Dec 2017).
- Feldman M, Walker P, Green JL, et al. Life events stress and psychosocial factors in men with peptic ulcer disease: a multidimensional case-controlled study. Gastroenterology 1986, 91, 1370–9. [Google Scholar] [CrossRef] [PubMed]
- Furuta T, Baba S, Takashima M, et al. Effect of Helicobacter pylori Infection on Gastric Juice pH. Scand J Gastroenterol 1998, 33, 357–63. [Google Scholar] [CrossRef]
- Peters MN, Richardson CT. Stressful Life Events, Acid Hypersecretion, and Ulcer Disease. Gastroenterology 1983, 84, 114–9. [Google Scholar] [CrossRef]
- Smith GD, Susser E. Zena Stein, Mervyn Susser and epidemiology: observation, causation and action. Int J Epidemiol 2002, 31, 34–7. [Google Scholar] [CrossRef] [PubMed]
- Glavin GB, Murison R, Overmier JB, et al. The neurobiology of stress ulcers. Brain Res Rev 1991, 16, 301–43. [Google Scholar] [CrossRef]
- Hernandez, DE. Neurobiology of brain-gut interactions. Implications for ulcer disease. Dig Dis Sci 1989, 34, 1809–16. [Google Scholar] [CrossRef]
- Hernandez, DE. The Role of Brain Peptides in the Pathogenesis of Experimental Stress Gastric Ulcers. Ann N Y Acad Sci 1990, 597, 28–35. [Google Scholar] [CrossRef]
- Sutoo D, Akiyama K, Matsui A. Gastric ulcer formation in cold-stressed mice related to a central calcium-dependent-dopamine synthesizing system. Neurosci Lett 1998, 249, 9–12. [Google Scholar] [CrossRef] [PubMed]
- Joëls M, Karst H, Alfarez D, et al. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 2004, 7, 221–31. [Google Scholar] [CrossRef] [PubMed]
- Henke, PG. Attenuation of shock-induced ulcers after lesions in the medial amygdala. Physiol Behav 1981, 27, 143–6. [Google Scholar] [CrossRef] [PubMed]
- Tanaka T, Yoshida M, Yokoo H, et al. Expression of aggression attenuates both stress-induced gastric ulcer formation and increases in noradrenaline release in the rat amygdala assessed by intracerebral microdialysis. Pharmacol Biochem Behav 1998, 59, 27–31. [Google Scholar] [CrossRef] [PubMed]
- Henke, PG. The centromedial amygdala and gastric pathology in rats. Physiol Behav 1980, 25, 107–12. [Google Scholar] [CrossRef] [PubMed]
- Henke, PG. The amygdala and forced immobilization of rats. Behav Brain Res 1985, 16, 19–24. [Google Scholar] [CrossRef]
- Tennant C, Goulston K, Langeluddecke P. Psychological correlates of gastric and duodenal ulcer disease. Psychol Med 1986, 16, 365–71. [Google Scholar] [CrossRef]
- Levenstein S, Prantera C, Scribano ML, et al. Psychologic predictors of duodenal ulcer healing. J Clin Gastroenterol 1996, 22, 84–9. [Google Scholar] [CrossRef]
- Magni G, Salmi A, Paterlini A, et al. Psychological distress in duodenal ulcer and acute gastroduodenitis. Dig Dis Sci 1982, 27, 1081–4. [Google Scholar] [CrossRef]
- Cho CH, Lai KH, Ogle CW, et al. The role of histamine and serotonin in gastric acid secretion: A comparative study in gastric and duodenal ulcer patients. J Gastroenterol Hepatol 1986, 1, 437–42. [Google Scholar] [CrossRef]
- Huang JQ, Hunt RH. pH, Healing rate and symptom relief in acid-related diseases. Yale J Biol Med 1996, 69, 159–74. [Google Scholar]
- Miner, P. Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment. Aliment Pharmacol Ther 2004, 20 Suppl 6, 20–9. [Google Scholar] [CrossRef]
- Konturek JW, Domschke W. Helicobacter pylori and gastric acid secretion. Z Gastroenterol 1999, 37, 187–94. [Google Scholar]
- Rademaker JW, Hunt RH. Helicobacter pylori and Gastric Acid Secretion: The Ulcer Link? Scand J Gastroenterol 1991, 26, 71–7. [Google Scholar] [CrossRef]
- Blair AJ, Feldman M, Barnett C, et al. Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. J Clin Invest 1987, 79, 582–7. [Google Scholar] [CrossRef]
- Boles, RS. Modern Medical and Surgical Treatment of Peptic Ulcer: An Appraisal. J Am Med Assoc 1948, 136, 528–35. [Google Scholar] [CrossRef] [PubMed]
- Malfertheiner P, Chan FKL, McColl KEL. Peptic ulcer disease. Lancet 2009, 374, 1449–61. [Google Scholar] [CrossRef] [PubMed]
- Parsonnet, J. Helicobacter pylori: the size of the problem. Gut 1998, 43, S6–9. [Google Scholar] [CrossRef] [PubMed]
- Chiu PWY. Bleeding peptic ulcers: the current management. Dig Endosc 2010, 22 Suppl 1, S19-21. [CrossRef]
- Schmassmann, A. Mechanisms of Ulcer Healing and Effects of Nonsteroidal Anti-inflammatory Drugs. Am J Med 1998, 104, 43S–51S. [Google Scholar] [CrossRef] [PubMed]
- Yeomans, ND. The ulcer sleuths: The search for the cause of peptic ulcers. J Gastroenterol Hepatol 2011, 26, 35–41. [Google Scholar] [CrossRef] [PubMed]
- Hawkey CJ, Wilson I, Naesdal J, et al. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Gut 2002, 51, 344–50. [Google Scholar] [CrossRef]
- Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56, 772–81. [Google Scholar] [CrossRef] [PubMed]
- Sonnenberg A, Müller H, Pace F. Birth-cohort analysis of peptic ulcer mortality in Europe. J Chronic Dis 1985, 38, 309–17. [Google Scholar] [CrossRef] [PubMed]
- Zetterström, R. The Nobel Prize in 2005 for the discovery of Helicobacter pylori: Implications for child health. Acta Paediatr Int J Paediatr 2006, 95, 3–5. [Google Scholar] [CrossRef]
| HP- (100 individuals) |
HP+ (100 individuals) |
HP- & HP+ (200 individuals) |
|
|---|---|---|---|
| Actual number of patients | 20 | 20 | 40 |
| Number of subclinical patients | 15* | 5* | 20* |
| Number of clinical patients | 5** | 15** | 20** |
| Clinical morbidity rates | 5% | 15% | 10% |
| Infection rates of clinical patients = 15 ÷ (5 + 15) = 15 ÷ 20c × 100% = 75% > H. pylori infection rates in the population = 100 ÷ 200 × 100% = 50% | |||
| The infection rate of H. pylori in a population is assumed to be 50%, and 100 individuals were analyzed in H. pylori-positive and negative groups, respectively. H. pylori infection exacerbates the symptoms of peptic ulcers and therefore, infected individuals are more likely to see doctors and become clinical patients (15 vs 5), causing a higher infection rate of H. pylori in clinical patients than that in the normal population (75% > 50%). * These subclinical patients (15 + 5 = 20) were excluded from the calculation of the clinical infection rate of H. pylori. ** Only clinical patients (5 + 15 = 20) were included in the calculation of the clinical infection rate of H. pylori. | |||
| Etiological Theory | Theory of H. Pylori [12] | Theory of Nodes [32,33,34,35,36] |
| 15 characteristics [5] | None of the 15 can be explained | All the 15 are fully explained |
| Etiology | Peptic ulcers are an infectious disease caused by the infection of H. pylori [12]. | Peptic ulcers are a psychosomatic disease triggered by psychological stress [32]. |
| Morphology of gastric ulcers [116] | Remains unknown | Explained, the only phenomenon needs to be verified [33]. |
| Predilection sites of gastric ulcers [117] | Remains unknown | Explained [33]. |
| Relapse and Multiplicity [87,118] | Remains unknown | Explained [33]. |
| Bleeding and Perforation [119] | Remains unknown | Explained [33]. |
| Epidemiology | 3 observations/phenomena were used as supporting evidences [17]; it might be able explain the other 3 observations. All the others remain unexplained. | All explained [32,33,34,35,36]. All 3 supporting evidences in Theory of H. pylori were identified as illusions, and the other 3 H. pylori explainable observations were mis-interpreted in Theory of H. pylori. |
|
81 observations/ Phenomenon [5] |
75 of 81 cannot be explained; 45 are unrelated to H pylori. | All 81 are explained; leaves no observations/phenomena unknown |
| 36 observations/phenomena associated with H. pylori |
30 of 36 cannot be explained. | All 36 are explained [32,33,34,35,36]. |
| 45 observations/phenomenon not associated with H. pylori | None can be explained because many patients are H. pylori-negative [38,54,55]. | All 45 are explained [32,33,34,35,36]. |
| 4 Controversies | None of the 4 is addressed | All 4 are addressed clearly |
| Roles of H. pylori | Controversial [14,22,23,24,25] | Addressed: H. pylori is not an etiological factor but plays a secondary role in only the late phase of ulceration [32,33,34]. |
| Roles of gastric acid | Unknown and controversial [14,112] | Addressed [32,33]. |
| Roles of NSAIDs | Unknown [28,56,73,120,121,122,123] | Addressed [32,33]. |
| Idiopathic peptic ulcers | Unknown [20,28,56] | Addressed [32,33]. |
| 3 Major Mysteries | None of the 3 is resolved | All 3 are resolved clearly. |
| Birth-cohort Phenomena [69,124] | Remains a mystery [69,70] | Resolved [35]. |
| Seasonal Variations [8] | Remains a mystery | Resolved [36]. |
| African Enigma [30] | Remains a mystery | Resolved in this article: identified as an illusion due to incorrect etiology. |
| Similarities and differences between gastric and duodenal ulcers [9,10] | Remains unknown. | Fully illustrated [33]. |
| Therapy/effect | Antiacid and antibiotics treatments are the primary therapy; relapse frequently | Psychological treatments are the primary therapy; no relapse [34]. |
| Summary |
|
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).